FindTrial
Sign In

Androgen Suppression

DRUG2 trials

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Mayo Clinic

Conditions

Prostate AdenocarcinomaProstate CancerStage IIB Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8Stage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8

Phase 2

Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer - Protocol 2
CompletedNCT02229734
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sProstate Cancer
Start: 2014-12-31End: 2021-06-01Target: 60Updated: 2021-06-04
Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy
CompletedNCT03570827
Mayo ClinicProstate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 +3
Start: 2018-05-14End: 2025-05-15Updated: 2026-05-26

Related Papers

A phase II trial of hypofractionated radiation therapy over five treatments for prostate cancer with high-risk features after radical prostatectomy: MC1754.
Journal of Clinical Oncology2022-02-16